CoCensys Inc., a neuropharmaceutical company based in Irvine,Calif., on Friday filed with the Securities and ExchangeCommission for an initial public offering of up to 2.5 millioncommon shares. ConCensys said it will use the proceeds forresearch and development, working capital and generalcorporate purposes. The offering will be made throughMontgomery Securities and Hambrecht and Quist Inc.

(c) 1997 American Health Consultants. All rights reserved.

No Comments